AgriCyte
- Sector
- Biotechnology
- Investment year
- 2027
- Stage
- Seed
- Location
- Ho Chi Minh City
Early cancer diagnosis remains expensive and slow
Category
Tags
NanoLab matches the investment thesis of HCM VIF
The core technology is deep, patent-protected and difficult to copy.
Solving a major medical problem of Ho Chi Minh City and emerging markets with clear needs.
The founding team comes from a research background and understands both science and the path to commercialisation.
There is already a working prototype and early market evidence for acceleration.
The people behind NanoLab
Team information will be updated after the business approves the announcement.
Itinerary is allowed to be published
The business does not have any milestones allowed to announce at this time.
What did HCM VIF do with NanoLab
Introducing 3 experimental hospitals
Connect medical facility Ho Chi Minh City to NanoLab to launch clinical control programme from Q4/2026.
Review patent documents
Together with the IP expert, complete the nano electrode layer protection application and medical device standard documents.
Recruit 6 R&D engineers
Connect a network of technical human resources to expand the sensor research team.
Arrange clean room hours
Arrange usage of shared clean room infrastructure to manufacture and test samples.
Connect regional distribution partners
Introducing biomedical equipment distribution channels in neighboring emerging markets.
